Find out which five companies had the biggest growth in share price between 4 January and 17 December, 2021.
The past year has not been without its challenges but overall it has turned out to be a better year for investors than 2020. “2021 was again dominated by the coronavirus pandemic, along with concern about higher inflation and monetary tightening but shares unlisted assets and balanced growth super funds saw strong returns,” pointed out AMP’s head of investment strategy & chief economist, Dr Shane Oliver. He noted that Aussie shares did better than AMP expected.
The ASX 200 started the year at 6,684.25. There was some volatility in the first half of the year before it hit a high of 7,628.92 on August 13. On Friday 17 December the ASX 200 closed at 7,303.97 – a fair bit higher than it was in January.
Some companies have performed better than others. Canstar crunched the numbers to come up with the top 10 shares on the ASX 200 based on the growth of the share price from 4 January (which was the first trading day of 2021) to 17 December. Keep in mind that past performance is not a reliable indicator of future performance, but the results are very impressive, as you can see from the table below.
The table also shows how much money you’d have if you had invested $1,000 in any of these shares. To put these numbers in context, Canstar’s calculations show that the total return for the S&P ASX 200 for the same period would have been 14.7% and $1,000 invested on 4 January would have been worth $1,147 on 17 December.
← Mobile/tablet users, scroll sideways to view full table →
| Code | Company | Opening Share Price 4 Jan 2021 |
Closing Share Price 17 Dec 2021 |
Percent Change |
Value of $1k Investment |
|---|---|---|---|---|---|
| NVX | Novonix Ltd | $1.22 | $8.94 | 632.8% | $7,328 |
| LTR | Liontown Resources Ltd | $0.34 | $1.56 | 357.4% | $4,574 |
| IMU | Imugene Ltd | $0.10 | $0.46 | 355.0% | $4,550 |
| PLS | Pilbara Minerals Ltd | $0.87 | $2.75 | 216.1% | $3,161 |
| UWL | Uniti Group Ltd | $1.71 | $4.64 | 171.3% | $2,713 |
| LYC | Lynas Rare EARTHS Ltd | $4.00 | $9.00 | 125.0% | $2,250 |
| PNI | Pinnacle Investment Management Group Ltd |
$7.25 | $15.41 | 112.6% | $2,126 |
| CHN | Chalice Mining Ltd | $4.00 | $8.45 | 111.3% | $2,113 |
| WTC | Wisetech Global Ltd | $30.77 | $58.52 | 90.2% | $1,902 |
| HMC | Home Consortium Ltd | $3.92 | $7.27 | 85.5% | $1,855 |
Source: www.canstar.com.au – 17/12/2021. Table sorted in descending order by percentage change.
The star performer of 2021 was battery materials and technology company Novonix Ltd (ASX: NVX). Its share price grew by a whopping 632.8% from $1.22 on 4 January to $8.94 on 17 December. That means a $1,000 investment at the beginning of the year could have turned into $7,328 by 17 December. It’s worth noting that the share price has tumbled in December after it hit a high of $12.47 on 2 December.
In second spot is Liontown Resources (ASX: LTR) which is a mineral exploration and development company focused on the development of high-quality lithium & tantalum projects in Australia. Its return of 357.4% might not be as high as that of Novonix but I don’t think many people would complain if they had invested $1,000 at the start of the year as they could have had $4,574 on 17 December.
Not far behind is Imugene (ASX: IMU), a biotechnology company working in cancer immunotherapy. Its share price grew by 355% from $0.10 on 4 January to $0.46 on 17 December. This is still a fair bit lower than its high of $0.61 in early November.
As you can see from the table, you can have potentially more than doubled your money with an investment of $1,000 in most of the stocks on the top 10 list. And you would have come close to it with Wisetech Global and Home Consortium which are ninth and tenth.
Cover image source: fizkes/Shutterstock.com
This article was reviewed by our Editor-at-Large Effie Zahos before it was updated, as part of our fact-checking process.
Try our Investor Hub comparison tool to instantly compare Canstar expert rated options.
This advice is general and has not taken into account your objectives, financial situation, or needs. It is not personal advice. Consider whether this advice is right for you, having regard to your own objectives, financial situation and needs. You may need financial advice from a suitably qualified adviser. For more information, read Canstar’s Financial Services and Credit Guide (FSCG) and our detailed disclosure. Canstar may receive a fee for referring you to a product provider – for further information, see how we get paid. Payment of fees for ads does not influence our Star Ratings or Awards.
Canstar is a comparison website, not a product issuer, so it’s important to check any product information directly with the provider. Consider the Product Disclosure Statement (PDS), Target Market Determination (TMD) and other applicable product documentation before making a decision to purchase, acquire, invest in or apply for a financial or credit product. Contact the product issuer directly for a copy of the PDS, TMD and other documentation.
Canstar is an information provider and in giving you product information Canstar is not making any suggestion or recommendation about a particular credit product or loan. If you decide to apply for a credit product or loan, you will deal directly with a credit provider, and not with Canstar. Rates and product information should be confirmed with the relevant credit provider. For more information, read the credit provider’s key facts sheet and other applicable loan documentation for that product. Read the Comparison Rate Warning.
All information about performance returns is historical. Past performance should not be relied upon as an indicator of future performance; unit prices and the value of your investment may fall or rise.
Canstar is an information provider and in giving you product information Canstar is not making any suggestion or recommendation about a particular product. The information has been prepared without taking into account your individual investment objectives, financial circumstances or needs. Before you decide whether or not to acquire a particular financial product you should assess whether it is appropriate for you in the light of your own personal circumstances, having regard to your own objectives, financial situation and needs. You may wish to obtain financial advice from a suitably qualified adviser before making any decision to acquire a financial product. Please refer to the product disclosure statement (PDS) and Canstar’s Financial Services and Credit Guide (FSCG) for more information, and read our detailed disclosure, important notes and liability disclaimer.
The examples provided in the article are not based on actual products or real consumer circumstances. The information in this article is of a general nature only, and does not take into consideration your objectives, financial situation or needs. It is not personal advice, and you should not rely on it, even if the example is similar to your own circumstances. You should make your own enquiries and calculations based on your own personal circumstances as well as finding out specific product costs, rates or features that may be relevant to you. You should consider seeking independent advice before making a purchase, credit, or investment decision.
The views, opinions and advice quoted in this piece are those of the author(s) or interviewee(s) expressing them, and do not necessarily reflect the views of Canstar. Any other views expressed and advice given by Canstar or its employee(s) in the above article are not necessarily those of the same author(s) or interviewee(s).
Canstar may earn a fee for referrals from its website tables, and from Sponsorship or Promotion of certain products. Fees payable by product providers for referrals and Sponsorship or Promotion may vary between providers, website position, and revenue model. Sponsorship or Promotion fees may be higher than referral fees. Sponsored or Promotion products are clearly disclosed as such on website pages. They may appear in a number of areas of the website such as in comparison tables, on hub pages and in articles. Sponsored or Promotion products may be displayed in a fixed position in a table, regardless of the product's rating, price or other attributes. The table position of a Sponsored or Promoted product does not indicate any ranking or rating by Canstar. For more information please see How We Get Paid.
Any advice provided on this website is general and has not taken into account your objectives, financial situation or needs. Consider whether this advice is right for you. Consider the Product Disclosure Statement and Target Market Determination before making a purchase decision. Canstar provides an information service. It is not a credit provider, and in giving you information about credit products Canstar is not making any suggestion or recommendation to you about a particular credit product. Research provided by Canstar Research AFSL and Australian Credit Licence No. 437917. You must not reproduce, transmit, disseminate, sell, or publish information on this website without prior written permission from Canstar.